TL;DR
Researchers have identified a specific type of mesenchymal cell, marked by RSPO2 expression, that plays a crucial role in maintaining the multipotency of human lung bud tip progenitor cells. This RSPO2-expressing niche is essential for proper human lung development, as its disruption leads to premature differentiation of these progenitor cells.
What Problem Does This Paper Address?
The development of the human lung is a complex process involving intricate signaling between epithelial and mesenchymal cells. While the epithelial side has been studied extensively, the heterogeneity and specific functions of mesenchymal cells in this process, particularly in the early stages of lung bud development, remain poorly understood. This lack of understanding hinders our ability to fully grasp the mechanisms governing lung formation and to potentially address developmental lung diseases. The authors aim to pinpoint specific mesenchymal cell populations and their signaling roles in supporting the critical "bud tip" progenitor cells, which are responsible for generating the entire lung epithelium.
Methods
The study employed a multi-pronged approach:
- Single-cell RNA sequencing (scRNA-seq): This was the cornerstone technique, used to analyze the transcriptional profiles of thousands of individual cells from developing human lung tissue. This allowed for the identification and classification of distinct mesenchymal cell populations.
- Fluorescence In Situ Hybridization (FISH) and Immunofluorescence (IF): These techniques were used to visualize the spatial localization of specific genes and proteins within tissue sections, confirming the proximity of identified cell populations and their molecular interactions.
- Organoid Models and Lung Explant Cultures: These in vitro systems allowed the researchers to manipulate and test the functional roles of specific cell populations and signaling pathways. This included using adenovirus-mediated gene delivery to inhibit RSPO2 signaling.
- Fluorescence-Activated Cell Sorting (FACS): This method was used to isolate specific mesenchymal cell populations based on cell surface markers for further functional studies.
Datasets
The study utilized single-cell RNA sequencing data from human fetal lung specimens (8-19 weeks post-conception). This data was generated by the authors and also re-analyzed from a previously published dataset (Miller et al., 2020).
Key Insights and Ideas
- RSPO2+ Mesenchyme as a Niche Component: The identification of a specific mesenchymal cell population expressing RSPO2, located precisely adjacent to bud tip progenitors, strongly suggests its role as a key component of the progenitor niche.
- LGR5 as the Receptor: The complementary expression of the RSPO2 receptor, LGR5, specifically on bud tip progenitors points to a direct signaling axis between these mesenchymal cells and the epithelial progenitors.
- WNT Signaling is Crucial: The study reinforces the critical role of WNT signaling in maintaining the multipotency of lung progenitors, with RSPO2 acting as a potent enhancer of this pathway.
- RSPO2 is Essential for Progenitor Maintenance: Disrupting RSPO2 signaling in vitro leads to the loss of bud tip progenitor identity and premature differentiation into proximal cell types, highlighting its necessity for maintaining the progenitor state.
- Mesenchymal Heterogeneity Matters: The study demonstrates that different mesenchymal cell populations (e.g., RSPO2+ vs. SM22+ smooth muscle cells) have distinct roles in supporting lung development, with RSPO2+ cells promoting multipotency and SM22+ cells potentially supporting proximal differentiation.
Key Results
- scRNA-seq analysis identified five distinct mesenchymal cell clusters, with three non-smooth muscle clusters being highly enriched for RSPO2 expression.
- FISH and IF confirmed that RSPO2-expressing mesenchymal cells are spatially located adjacent to bud tip progenitors, while airway smooth muscle cells (SM22+) line the proximal epithelium.
- LGR5, but not other LGR family members, was uniquely expressed in bud tip progenitors, suggesting it's the primary receptor for RSPO2 in this context.
- WNT target gene expression, as measured by AXIN2, was significantly enriched in bud tip progenitors.
- Inhibition of RSPO2 signaling using a soluble LGR5 ECD adenovirus in human fetal lung explants led to a loss of bud tip identity (reduced SOX9 expression) and increased differentiation into proximal cell types (increased SOX2, SCGB3A2, and TP63 expression).
- FACS-isolated RSPO2+ mesenchymal cells (LIFRHI) supported the multipotency of bud tip organoids, allowing differentiation into both proximal and distal cell types, whereas SM22+ mesenchymal cells (LIFR-) primarily supported proximal differentiation.
Limitations and Future Work
- Genetic Loss-of-Function in Humans: The authors acknowledge that performing genetic loss-of-function studies directly in human tissue to definitively prove the necessity of RSPO2 is challenging. They suggest that alternative mechanisms of RSPO2 action (independent of LGRs) might exist and warrant further investigation.
- Mouse vs. Human Phenotypes: While RSPO2 mutations are lethal in humans, Rspo2 knockout mice exhibit milder lung defects. The paper speculates on reasons for this discrepancy, including potential compensation by other Rspo family members in mice and a possible unique role of RSPO2 in initiating early human lung branching.
- Complex Mesenchymal Interactions: The study highlights the distinct roles of RSPO2+ and SM22+ mesenchymal cells, but acknowledges that the intricate dynamics and potential interconversion between these cell types during human lung development require further exploration.
- Broader Signaling Network: The authors suggest that understanding how other cell types and signaling pathways integrate with the RSPO2-mediated WNT signaling network to regulate bud tip progenitor behavior is a crucial area for future research.
Summary updated